Gene Therapy
Gene Therapy at a Crossroads: What the Sarepta Crisis Reveals — and What Comes Next
David Alvaro, Ph.D.; April Stanley, MS MBA; Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-08-25-NI-02Aug 05, 2025
FDA Priority Review
[Fam-] Trastuzumab Deruxtecan Granted FDA Priority Review for Treatment of Patients With HER2-positive Metastatic Breast Cancer
AstraZeneca
PR-M10-19-NI-025Oct 17, 2019
FDA Review
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Daiichi-Sankyo
PR-M06-19-NI-045Jun 26, 2019